• Sign In
  • My Marketwire Account
  • Marketwire Resonate
  • News Dashboard 2.0
  • Mediahub
  • Personal Beat
  • Hot Off the Wire
• Register
• Français
• Marketwired Blog
• Careers
• Contact Marketwired

Browse By:

• Industry
  • Aerospace and Defense
  • Agriculture
  • Automotive
  • Chemicals
  • Computers and Software
  • Education and Training
  • Electronics and Semiconductors
  • Energy and Utilities
  • Environment
  • Financial Services
  • Food and Beverage
  • Government
  • Lifestyle and Leisure
  • Manufacturing and Production
  • Media and Entertainment
  • Medical and Healthcare
  • Pharmaceuticals and Biotech
  • Professional Services
  • Real Estate and Construction
  • Retail
  • Sports
  • Telecom
  • Transportation and Logistics
  • Travel and Hospitality
• Topic
  • Associations
  • Bankruptcy
  • Class action
  • Conference calls
  • Dividends
  • Earnings
  • Earnings projections
  • Financing agreements
  • Initial public offerings
  • Investment opinion
  • Management changes
  • Media advisory
  • Mergers and acquisitions
  • Special news events
  • Stock splits
  • Stock/other market news
  • Trade shows
  • Webcasts
• Type
  • News Releases
  • Media Advisories
  • Feature Packs
  • Webcasts
  • Social Media 2.0

News Room: Drugs

SciClone Reports Anticipated Financial Results for the First Quarter 2013
FOSTER CITY, CA--(Marketwired - May 16, 2013) - SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported its expectations regarding financial results for the quarter ended March 31, 2013. ...(more)
SciClone Pharmaceuticals, Inc.  
May 16, 2013 16:00 ET
 

 

SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China Market
FOSTER CITY, CA--(Marketwired - May 16, 2013) -  SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that the Company has entered into an agreement with Zensun (Shanghai) Science...(more)
SciClone Pharmaceuticals, Inc.  
May 16, 2013 16:00 ET
 

 

NewLink Genetics to Be Added to NASDAQ Biotechnology Index
AMES, IA--(Marketwired - May 16, 2013) -  NewLink Genetics Corporation (NASDAQ: NLNK), an oncology-focused biopharmaceutical company specializing in immunotherapy, today announced that it has...(more)
NewLink Genetics Corporation  
May 16, 2013 08:10 ET
 

 

NewLink Genetics to Present Data on Cancer Immunotherapy Programs at the ASCO 2013 Annual Meeting
AMES, IA--(Marketwired - May 16, 2013) - NewLink Genetics Corporation (NASDAQ: NLNK), an oncology-focused biopharmaceutical company specializing in immunotherapy, today announced that several...(more)
NewLink Genetics Corporation  
May 16, 2013 08:05 ET
 

 

Stem Cell Therapeutics to Begin Trading on the U.S. OTCQX Marketplace
TORONTO, ONTARIO--(Marketwired - May 16, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS), a biopharmaceutical company developing cancer stem cell-related technologies, today...(more)
Stem Cell Therapeutics Corp.  
May 16, 2013 07:30 ET
 

 

Stem Cell Therapeutics Announces Completion of Dosing in Phase I Study of TTI-1612 in Patients With Interstitial Cystitis/Bladder Pain Syndrome
TORONTO, ONTARIO--(Marketwired - May 16, 2013) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS), a biopharmaceutical company developing cancer stem cell-related technologies, today...(more)
Stem Cell Therapeutics Corp.  
May 16, 2013 07:00 ET
 

 

Pharmaceutical-Biotech Industry to Pull Plug on 30 North American Sites in 2013, an Industrial Info News Alert
SUGAR LAND, TX--(Marketwired - May 16, 2013) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- In a case of bad news being not quite as bad as it could be, the...(more)
Industrial Info Resources  
May 16, 2013 06:15 ET
 

 

Vital Therapies, Inc. Adds Two New Board Members
SAN DIEGO, CA--(Marketwired - May 16, 2013) - Vital Therapies, Inc., a development stage biotechnology company focused on developing the first bio-artificial liver for life-threatening acute...(more)
Vital Therapies  
May 16, 2013 06:00 ET